Chemir Pharma Services Changes Name to Azopharma

PharmaManufacturing.com
07/01/2005

Effective July 1, Chemir Pharma Services has changed its name to Azopharma in response to extensive growth and commitment as a contract pharmaceutical services provider.

Azopharma continues to support specific stand-alone cGMP services and complete Phase I development programs, including the manufacturing of clinical trial material.

Azopharma’s Phase I Express enables pharmaceutical companies to move quickly and efficiently toward clinical trials. Phase I Express includes preformulation, formulation, analytical R&D, QC release, stability, manufacturing, packaging and labeling of clinical supplies for Phase I development.

“Timing is a critical factor on the road to successful clinical study,” said Phil Meeks, CEO of Azopharma. “We can now assist our customers in all phases of drug development for Phase I clinical supplies. Our Phase I Express will raise the bar in the industry and bring unsurpassed speed to the development of clinical materials.

“In product development, it all comes down to the scientists, their commitment and the application of experience," he continued. "Partnering with the right people with the right experience can give you the confidence of assured success. Over the past two years, we have experienced significant growth…thanks to our customers’ belief in us and our service and commitment to them."

For more information, contact:
Phil Meeks, CEO, Azopharma
10320 USA Today Way
Miramar, FL 33025
(954) 433-7480
www.azopharma.com